Etanercept (Enbrel ®) is an injectable fusion protein that competitively inhibits the pro-inflammatory cytokine TNF-α. It is approved for use in rheumatoid arthritis, juvenile rheumatoid ...

Patients in the etanercept group showed significant improvements in morning stiffness, spinal pain, functioning, QOL, enthesitis, chest expansion, ESR, and C-reactive protein (CRP) level.